Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Machine Learning Assessment Of Next-Day Migraine Likelihood Collected Via The Nerivio App

NCT07227194 is registered in ClinicalTrials.gov with Theranica as lead sponsor.

NCT NCT07227194
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07227194 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Machine Learning Assessment Of Next-Day Migraine Likelihood Collected Via The Nerivio App
Lead sponsor
Theranica
Phase
Observational
Overall status
Completed
Start date
February 7, 2025
Completion date
August 20, 2025
Enrollment
53,065 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine